From the Departments of Neurosurgery (M.E.N., L.D.N., M.A.M., T.B.M.), Neurology (L.D.N., M.A.M.), Cell Biology, Neurobiology and Anatomy (T.B.M.), and Biomedical Engineering (T.B.M.), Medical College of Wisconsin; Department of Psychology (M.E.N., J.B.H.), Marquette University, Milwaukee, WI; Laureate Institute for Brain Research (J.S.), Tulsa; Oxley College of Health Sciences (J.S.), The University of Tulsa; Departments of Surgery (T.K.T.) and Psychiatry (T.K.T.), University of Oklahoma School of Community Medicine; Department of Pharmaceutical Sciences (T.K.T.), University of Oklahoma College of Pharmacy; and Department of Biochemistry and Microbiology (T.K.T.), Oklahoma State University Center for Health Sciences, Tulsa.
Neurology. 2019 Jul 30;93(5):e497-e507. doi: 10.1212/WNL.0000000000007864. Epub 2019 Jul 3.
To test the hypothesis that acute elevations in serum inflammatory markers predict symptom recovery after sport-related concussion (SRC).
High school and collegiate football players (n = 857) were prospectively enrolled. Forty-one athletes with concussion and 43 matched control athletes met inclusion criteria. Serum levels of interleukin (IL)-6, IL-1β, IL-10, tumor necrosis factor, C-reactive protein, interferon-γ, and IL-1 receptor antagonist and Sport Concussion Assessment Tool, 3rd edition (SCAT3) symptom severity scores were collected at a preinjury baseline, 6 and 24-48 hours postinjury, and approximately 8, 15, and 45 days following concussion. The number of days that athletes were symptomatic following SRC (i.e., duration of symptoms) was the primary outcome variable.
IL-6 and IL-1RA were significantly elevated in athletes with concussion at 6 hours relative to preinjury and other postinjury visits, as well as compared to controls ( ≤ 0.001). IL-6 and IL-1RA significantly discriminated concussed from control athletes at 6 hours postconcussion (IL-6 area under receiver operating characteristic curve 0.79 [95% confidence interval (CI) 0.65-0.92], IL-1RA AUC 0.79 [95% CI 0.67-0.90]). Further, IL-6 levels at 6 hours postconcussion were significantly associated with the duration of symptoms (hazard ratio for symptom recovery = 0.61 [95% CI 0.38-0.96], = 0.031).
Results support the potential utility of IL-6 and IL-1RA as serum biomarkers of SRC and demonstrate the potential of these markers in identifying athletes at risk for prolonged recovery after SRC.
This study provides Class III evidence that serum levels of IL-6 and IL-1RA 6 hours postconcussion significantly discriminated concussed from control athletes.
验证血清炎症标志物在运动相关脑震荡(SRC)后症状恢复中的预测作用。
前瞻性纳入高中和大学橄榄球队员(n=857)。41 名患有脑震荡的运动员和 43 名匹配的对照组运动员符合纳入标准。在损伤前基线、损伤后 6 小时和 24-48 小时以及脑震荡后约 8、15 和 45 天,采集血清白细胞介素(IL)-6、IL-1β、IL-10、肿瘤坏死因子、C 反应蛋白、干扰素-γ 和 IL-1 受体拮抗剂及运动性脑震荡评估工具第 3 版(SCAT3)症状严重程度评分。运动员 SRC 后出现症状的天数(即症状持续时间)为主要观察结果。
与损伤前和其他损伤后就诊时以及与对照组相比,脑震荡运动员在 6 小时时的 IL-6 和 IL-1RA 显著升高(≤0.001)。IL-6 和 IL-1RA 在脑震荡后 6 小时可显著区分脑震荡运动员和对照组(IL-6 受试者工作特征曲线下面积 0.79[95%置信区间(CI)0.65-0.92],IL-1RA AUC 0.79[95% CI 0.67-0.90])。此外,脑震荡后 6 小时的 IL-6 水平与症状持续时间显著相关(症状恢复的危险比=0.61[95% CI 0.38-0.96],=0.031)。
结果支持 IL-6 和 IL-1RA 作为 SRC 血清生物标志物的潜在效用,并表明这些标志物在识别 SRC 后恢复时间延长的运动员方面具有潜力。
本研究提供了 III 级证据,表明脑震荡后 6 小时的血清 IL-6 和 IL-1RA 水平可显著区分脑震荡运动员和对照组运动员。